Supreme Court Chief Justice Denies Teva’s Request for an Injunction Relating to Generic Copaxone®; Clears Legal Hurdle for Mylan to Launch at Market Formation

[PR Newswire] – PITTSBURGH, April 18, 2014 /PRNewswire/ — Mylan Inc. (MYL) today announced that Supreme Court Chief Justice Roberts has denied Teva’s application for an injunction seeking to prevent Mylan’s launch of a generic version of Copaxone® pend more

View todays social media effects on MYL

View the latest stocks trending across Twitter. Click to view dashboard

See who Mylan is hiring next, click here to view